Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
Oliver W. Press(Cancer Research Center), Irwin D. Bernstein(University of Washington), Janet F. Eary(University of Washington), Darning Shan(Women's Health Research Institute), Frederick R. Appelbaum(City Of Hope National Medical Center), Lois M. Hinman(Immunomedics (Germany)), J Howell-Clark(University of Washington), David J. King(Regulus Therapeutics (United States)), Dana C. Matthews(Fred Hutch Cancer Center), Philip Hamann(Women's Health Research Institute), Adrian M.R. Haines, D Shochat(Senju Pharmaceutical (United States))
PubMed
May 1, 1996
Cited by 212
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k